Resultantly, the inhibitory effect of phenformin on G-MDSC-driven immune suppression induces CD8+ T-cell infiltration and improves the antitumor activity of PD-1 blockade immunotherapy in melanoma (105). Here, PDCD1 is linked to melanoma.